The importance of reducing SFA to limit CHD

British Journal of Nutrition

Volumn 106, Issue 7, 2011, Pages 961-963

  Pedersen, Jan I ^a   James, Philip T ^b   Brouwer, Ingeborg A ^c   Clarke, Robert ^d   Elmadfa, Ibrahim ^e   Katan, Martijn B ^c   Kris Etherton, Penny M ^f   Kromhout, Daan ^g   Margetts, Barrie M ^h   Mensink, Ronald P ⁱ   Norum, Kaare R ^a   Rayner, Mike ^d   Uusitupa, Matti ^j  

^a UNIVERSITY OF OSLO   (Norway)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF VIENNA   (Austria)

^f PENNSYLVANIA STATE UNIVERSITY   (United States)

^g WAGENINGEN UNIVERSITY   (Netherlands)

^h UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

ⁱ MAASTRICHT UNIVERSITY   (Netherlands)

^j UNIVERSITY OF EASTERN FINLAND   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; FATTY ACID;

ALCOHOL ABSTINENCE; ATHEROSCLEROSIS; AWARENESS; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FAT INTAKE; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; ISCHEMIC HEART DISEASE; PREVENTION AND CONTROL; PUBLIC HEALTH PROBLEM; RISK FACTOR; RISK REDUCTION; SALT INTAKE; SMOKING CESSATION; SUGAR INTAKE; THERAPY EFFECT; CHEMISTRY; CORONARY ARTERY DISEASE;

CORONARY DISEASE; DIETARY FATS; FATTY ACIDS; HUMANS; RISK FACTORS;

EID: 84856380112     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451100506X     Document Type: Editorial

References (27)

1. Siri-Tarino PW, Sun Q, Hu FB, et al. (2010) Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 91, 502-509.
2. Siri-Tarino PW, Sun Q, Hu FB, et al. (2010) Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 91, 535-546.
3. Kromhout D, Geleijnse JM, Menotti A, et al. (2011) The confusion about dietary fatty acids recommendations for CHD prevention. Br J Nutr 106, 627-632.
4. Beaglehole R, Bonita R, Adams C, et al. (2011) Priority actions for the non-communicable disease crisis. Lancet 378, 566-567.
5. World Health Organization (2011) http://www.who.int/nmh/events/moscow- ncds-2011/conference-documents/en/
6. World Health Organization (2011) http://www.ncdalliance. org/resources/speeches
7. Micha R & Mozaffarian D (2010) Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids 45, 893-905.
8. Astrup A, Dyerberg J, Elwood P, et al. (2010) The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? Am J Clin Nutr 93, 684-688.
9. Mozaffarian D, Micha R & Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med 7, e1000252.
10. Campbell TC, Parpia B & Chen J (1998) Diet, lifestyle, and the etiology of coronary artery disease: The Cornell China study. Am J Cardiol 82, 18T-21T. (Pubitemid 29006628)
11. Campbell TC & Chen J (1999) Energy balance: Interpretation of data from rural China. Toxicol Sci 52, Suppl. 2, 87-94. (Pubitemid 30017580)
12. Stamler J (2010) Diet-heart: A problematic revisit. Am J Clin Nutr 91, 497-499.
13. Scarborough P, Rayner M, van Dis I, et al. (2010) Metaanalysis of effect of saturated fat intake on cardiovascular disease: Over adjustment obscures true associations. Am J Clin Nutr 92, 458-459.
14. Katan MB, Brouwer IA, Clarke R, et al. (2010) Saturated fat and heart disease. Am J Clin Nutr 92, 459-460.
15. Fewell Z, Davey Smith G & Sterne JA (2007) The impact of residual and unmeasured confounding in epidemiologic studies: A simulation study. Am J Epidemiol 166, 646-655. (Pubitemid 47347902)
16. Mozaffarian D, Aro D & Willett WC (2009) Health effects of trans-fatty acids: Experimental and observational evidence. Eur J Clin Nutr 63, S5-S21.
17. Stender S & Dyerberg J (2004) Influence of trans fatty acids on health. Ann Nutr Metab 48, 61-66. (Pubitemid 38490244)
18. Glass CK & Witztum JL (2001) Atherosclerosis: The road ahead. Cell 104, 503-516. (Pubitemid 32201946)
19. Tabas I, Williams KJ & Borén J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis. Update and therapeutic implications. Circulation 116, 1832-1844. (Pubitemid 350287108)
20. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 375, 132-140.
21. Mensink RP, Zock PL, Kester ADM, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146-1155. (Pubitemid 44858429)
22. Ford ES & Capewell S (2011) Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: Public health versus clinical care. Annu Rev Public Health 32, 5-22.
23. Laatikainen T, Critchley J, Vartiainen E, et al. (2005) Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162, 764-773. (Pubitemid 41437763)
24. Vartiainen E, Laatikainen T, Peltonen M, et al. (2010) Thirtyfive- year trends in cardiovascular risk factors in Finland. Int J Epidemiol 39, 504-518.
25. Valsta LM, Tapanainen H, Sundvall J, et al. (2010) Explaining the 25-year decline of serum cholesterol by dietary changes and use of lipid-lowering medication in Finland. Public Health Nutr 13, 932-938.
26. Pedersen JI, Tverdal A & Kirkhus B (2004) Diet changes and the rise and fall of cardiovascular disease mortality in Norway. Tidsskr Nor Laegeforen 124, 1532-1536. (Pubitemid 40311171)
27. Aspelund T, Gudnason V, Magnusdottir BT, et al. (2010) Analysing the large decline in coronary heart disease mortality in the icelandic population aged 25-74 between the years 1981 and 2006. PLoS ONE 5, e13957.